Category: Investor updates

Imagion Biosystems is pleased to announce it has entered into a Joint Development Agreement with Global Cancer Technology (GCT), to develop GCT’s novel nanoscintillator technology

The document “Notification of Cessation of +Securities” was lodged with ASX on 5 August 2021. Please click to review the full announcement at ASX.

Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 30 June 2021. The report highlights that during the quarter

The document “Application for Quotation of +Securities” was lodged with ASX on 1 July 2021. Please click to review the full announcement at ASX.  

Imagion Biosystems announces on ASX that it has received a total of $3500 for the exercise of 70,000 Listed Options exercisable at 5 cents, expiring on

The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 30th June, 2021. Please click to review the

The document “Notification of Cessation of +Securities” was lodged with ASX on 22 June, 2021. Please click to review the full announcement at ASX.

The document “Application for Quotation of +Securities” was lodged with ASX on 17 June, 2021. Please click to review the full announcement at ASX.

Imagion Biosystems announces on ASX that it has received a total of $18,460.05 for the exercise of 363,201 Listed Options exercisable at 5 cents, expiring

The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 17 June, 2021. Please click to review the